Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1990 1
1995 1
1996 2
1997 2
1998 6
1999 3
2000 3
2001 4
2002 2
2003 2
2004 3
2005 3
2006 4
2007 1
2008 2
2010 2
2011 3
2012 2
2014 3
2015 4
2016 4
2018 5
2019 6
2020 6
2021 2
2022 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

72 results

Results by year

Filters applied: . Clear all
Page 1
Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer.
Spigel DR, Faivre-Finn C, Gray JE, Vicente D, Planchard D, Paz-Ares L, Vansteenkiste JF, Garassino MC, Hui R, Quantin X, Rimner A, Wu YL, Özgüroğlu M, Lee KH, Kato T, de Wit M, Kurata T, Reck M, Cho BC, Senan S, Naidoo J, Mann H, Newton M, Thiyagarajah P, Antonia SJ. Spigel DR, et al. Among authors: vansteenkiste jf. J Clin Oncol. 2022 Apr 20;40(12):1301-1311. doi: 10.1200/JCO.21.01308. Epub 2022 Feb 2. J Clin Oncol. 2022. PMID: 35108059 Free PMC article. Clinical Trial.
Four-Year Survival With Durvalumab After Chemoradiotherapy in Stage III NSCLC-an Update From the PACIFIC Trial.
Faivre-Finn C, Vicente D, Kurata T, Planchard D, Paz-Ares L, Vansteenkiste JF, Spigel DR, Garassino MC, Reck M, Senan S, Naidoo J, Rimner A, Wu YL, Gray JE, Özgüroğlu M, Lee KH, Cho BC, Kato T, de Wit M, Newton M, Wang L, Thiyagarajah P, Antonia SJ. Faivre-Finn C, et al. Among authors: vansteenkiste jf. J Thorac Oncol. 2021 May;16(5):860-867. doi: 10.1016/j.jtho.2020.12.015. Epub 2021 Jan 19. J Thorac Oncol. 2021. PMID: 33476803 Free article. Clinical Trial.
Immunotherapy: Beyond Anti-PD-1 and Anti-PD-L1 Therapies.
Antonia SJ, Vansteenkiste JF, Moon E. Antonia SJ, et al. Among authors: vansteenkiste jf. Am Soc Clin Oncol Educ Book. 2016;35:e450-8. doi: 10.1200/EDBK_158712. Am Soc Clin Oncol Educ Book. 2016. PMID: 27249753 Free article. Review.
Capmatinib for the treatment of non-small cell lung cancer.
Vansteenkiste JF, Van De Kerkhove C, Wauters E, Van Mol P. Vansteenkiste JF, et al. Expert Rev Anticancer Ther. 2019 Aug;19(8):659-671. doi: 10.1080/14737140.2019.1643239. Epub 2019 Aug 1. Expert Rev Anticancer Ther. 2019. PMID: 31368815 Review.
Predictive biomarkers for response to EGFR-directed monoclonal antibodies for advanced squamous cell lung cancer.
Bonomi PD, Gandara D, Hirsch FR, Kerr KM, Obasaju C, Paz-Ares L, Bellomo C, Bradley JD, Bunn PA Jr, Culligan M, Jett JR, Kim ES, Langer CJ, Natale RB, Novello S, Pérol M, Ramalingam SS, Reck M, Reynolds CH, Smit EF, Socinski MA, Spigel DR, Vansteenkiste JF, Wakelee H, Thatcher N. Bonomi PD, et al. Among authors: vansteenkiste jf. Ann Oncol. 2018 Aug 1;29(8):1701-1709. doi: 10.1093/annonc/mdy196. Ann Oncol. 2018. PMID: 29905778 Free PMC article. Review.
Immunotherapy in lung cancer.
Vansteenkiste JF. Vansteenkiste JF. ESMO Open. 2018 Jan 9;3(1):e000311. doi: 10.1136/esmoopen-2017-000311. eCollection 2018. ESMO Open. 2018. PMID: 29344409 Free PMC article. No abstract available.
Molecular and Immune Biomarker Testing in Squamous-Cell Lung Cancer: Effect of Current and Future Therapies and Technologies.
Hirsch FR, Kerr KM, Bunn PA Jr, Kim ES, Obasaju C, Pérol M, Bonomi P, Bradley JD, Gandara D, Jett JR, Langer CJ, Natale RB, Novello S, Paz-Ares L, Ramalingam SS, Reck M, Reynolds CH, Smit EF, Socinski MA, Spigel DR, Stinchcombe TE, Vansteenkiste JF, Wakelee H, Thatcher N. Hirsch FR, et al. Among authors: vansteenkiste jf. Clin Lung Cancer. 2018 Jul;19(4):331-339. doi: 10.1016/j.cllc.2018.03.014. Epub 2018 Mar 21. Clin Lung Cancer. 2018. PMID: 29773328 Free article. Review.
Lung cancer: progress in diagnosis, staging and therapy.
Spiro SG, Tanner NT, Silvestri GA, Janes SM, Lim E, Vansteenkiste JF, Pirker R. Spiro SG, et al. Among authors: vansteenkiste jf. Respirology. 2010 Jan;15(1):44-50. doi: 10.1111/j.1440-1843.2009.01674.x. Respirology. 2010. PMID: 20199634 Review.
72 results